Edition:
United States

Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

115.35SEK
5:42am EST
Change (% chg)

-0.20kr (-0.17%)
Prev Close
115.55kr
Open
115.35kr
Day's High
115.50kr
Day's Low
114.80kr
Volume
135,853
Avg. Vol
1,087,313
52-wk High
182.06kr
52-wk Low
112.75kr

Latest Key Developments (Source: Significant Developments)

Getinge says plans guaranteed rights issue of approximately SEK 4 bln
Wednesday, 14 Jun 2017 06:15am EDT 

June 14 (Reuters) - Getinge :Says plans guaranteed rights issue of approximately SEK 4 billion.Says is planning a new share issue of approximately SEK 4 billion to strengthen group's balance sheet by reducing debt and thereby creating greater scope for action.Says work on planned spin-off is proceeding according to previously announced plan.Says principal owner, Carl Bennet AB, representing 18.1 pct of share capital and 48.9 pct of number of votes in Getinge, has undertaken to vote in favor of and subscribe for its portion of new share issue.Furthermore, in an agreement with Getinge, Carl Bennet AB has undertaken to subscribe for the shares that potentially are not subscribed and paid for by the remaining shareholders.The Fourth Swedish National Pension Fund has expressed support for the right issue and has the intention to subscribe for its portion.  Full Article

Getinge: can't rule out more costs related to FDA quality control probe
Thursday, 26 Jan 2017 10:07am EST 

Getinge Ab CEO told analysts and media in a conference call: cannot rule out additional requirements from fda, costs related to fda quality controls probe . complementary acquisitions is as always on agenda Further company coverage: [GETIb.ST] (Reporting By Anna Ringstrom) ((Anna.Ringstrom@thomsonreuters.com;)).  Full Article

Getinge Q4 core profit below expectations
Thursday, 26 Jan 2017 07:00am EST 

Getinge : Q4 net sales increased by 1.1% to sek 9,523 m (9,417). . Getinge q4 order intake increased by 3.1% to sek 8,582 m (8,326). Order intake declined organically by 1.1%. . Says outlook for 2017: slightly positive organic sales growth for full-year. . Getinge q4 ebita. improved by 2.6% to sek 1,970 m (1,920) . Says a dividend per share of sek 2.00 (2.80) is proposed, corresponding to sek 477 m (667). . Says continued remediation activities related to consent decree with fda . Says currency transaction effects are expected to have a positive impact of approximately sek 200 m on the group’s 2017 earnings . Fin consequences of the consent decree with the fda., ex reconstruction costs, are related to loss of revenue and are expected to have a negative impact of abt sek 50 m on 2017 operating profit . Is still awaiting the fda’s decision on the action plan related to the production unit in hechingen .Reuters poll: getinge q4 order intake was seen at 8,561 million sek, adjusted. Ebita at 2,156 million.  Full Article

Getinge fires chief executive
Monday, 22 Aug 2016 02:00am EDT 

Getinge : Replacement of president & CEO getinge group:Joacim Lindoff appointed acting president & CEO of Getinge Group . Says President & CEO Alex Myers is leaving his position . Says change will be effective as of today . Says Board of Directors and Alex Myers have different views on the future direction of the Getinge Group and the board has therefore concluded that a replacement of the President & CEO is necessary . Says process to recruit a new president & CEO of the Getinge Group will commence immediately .Lindoff recently served as executive vice president of the business area Infection Control and has since January 1, 2016, headed up Getinge Surgical Workflows and is a member of the executive team.  Full Article

Getinge: 2016 sales growth outlook is unchanged, only wording differs vs Q1 report
Thursday, 14 Jul 2016 02:35am EDT 

Getinge Ab : Spokesperson says only wording of 2016 outlook is changed, view of sales growth is unchanged compared to Q1 report Further company coverage: [GETIb.ST] ((Sven.Nordenstam@thomsonreuters.com;)).  Full Article

Getinge Q2 core profit, order intake below forecasts
Thursday, 14 Jul 2016 02:00am EDT 

Getinge : Q2 order intake: -0.7 pct to sek 7,460 m (7,516). Order intake grew organically by 3.0 pct. . Q2 net sales: -3.5 pct to sek 6,927 m (7,181). Net sales fell organically by 0.3 pct . Q2 adjusted EBITA: +10.2 pct to sek 788 m . Reuters poll: Q2 order intake was seen at 7,546 mln sek, adjusted EBITA at 867 mln . Says is still awaiting a decision by FDA regarding remediation plan in Hechingen . Says outlook changed . Says expects moderate organic sales growth in 2016 .Previous sales outlook was "All in all, revenue growth is deemed to be positive in 2016.".  Full Article

Templeton Global Advisors cuts Getinge stake to 4.88 percent of votes
Thursday, 2 Jun 2016 08:55am EDT 

Getinge Ab :Templeton Global Advisors, Ltd cuts stake to 4.88 percent of votes, a FSA filing shows on Thursday.  Full Article

UPDATE 1-Getinge sets new financial targets ahead of Arjo listing

Nov 10 Swedish medical technology firm Getinge on Friday announced new financial targets following the proposed distribution and separate listing of its patient & post-acute care business, now called Arjo.